VERONA PHARMA PLC - AMERICAN DEPOSITARY SHARES

Verona Pharma to Present at H.C. Wainwright 23rd Annual Global Investment Conference

31 Aug 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update

05 Aug 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma Announces August 2021 Virtual Investor Conference Participation

27 Jul 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma to Report Second Quarter 2021 Financial Results and Provide Corporate Update

22 Jul 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China

10 Jun 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma to Present at Jefferies Virtual Healthcare Conference

25 May 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference

04 May 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease

27 Apr 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

23 Apr 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma to Report First Quarter 2021 Financial Results and Provide Corporate Update

21 Apr 2021 02:00:00 By Nasdaq GlobeNewswire

Lisa Deschamps Joins Verona Pharma as Non-Executive Director

02 Mar 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference

01 Mar 2021 02:00:00 By Nasdaq GlobeNewswire

Verona Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

25 Feb 2021 02:00:00 By Nasdaq GlobeNewswire